tiprankstipranks
Aeolus Pharmaceuticals Inc (AOLS)
OTHER OTC:AOLS
US Market

Aeolus Pharmaceuticals (AOLS) Financial Statements

12 Followers

Aeolus Pharmaceuticals Financial Overview

Aeolus Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Aeolus Pharmaceuticals is scheduled to report earnings on May 15, 2017, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 17Mar 17Dec 16Sep 16Jun 16
Income Statement-
Total Revenue$ 13.00K$ 129.00K$ 83.00K$ 546.00K$ 660.00K
Gross Profit-----
EBIT$ -949.00K$ -1.03M$ -1.09M$ -1.02M$ -872.00K
EBITDA$ -949.00K$ -1.03M$ -1.09M$ -1.02M$ -872.00K
Net Income Common Stockholders$ -949.00K$ -1.03M$ -1.09M$ -1.02M$ -872.00K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 403.00K$ 981.00K$ 1.90M$ 3.15M$ 3.76M
Total Assets$ 794.00K$ 1.76M$ 2.65M$ 4.17M$ 4.87M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -403.00K$ -981.00K$ -1.90M$ -3.15M$ -3.76M
Total Liabilities$ 587.00K$ 638.00K$ 514.00K$ 972.00K$ 688.00K
Stockholders Equity$ 207.00K$ 1.13M$ 2.13M$ 3.19M$ 4.18M
Cash Flow-
Free Cash Flow$ -578.00K$ -914.00K$ -1.26M$ -601.00K$ -753.00K
Operating Cash Flow$ -578.00K$ -914.00K$ -1.26M$ -601.00K$ -753.00K
Investing Cash Flow-----
Financing Cash Flow$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Currency in USD

Aeolus Pharmaceuticals Earnings and Revenue History

Aeolus Pharmaceuticals Debt to Assets

Aeolus Pharmaceuticals Cash Flow

Aeolus Pharmaceuticals Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis